OOIR: Observatory of International Research

Papers

(The TQCC of JAMA Psychiatry is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-07-01 to 2024-07-01.)

Article	Citations
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder	669
Suicide Mortality and Coronavirus Disease 2019—A Perfect Storm?	631
Internet-Based Cognitive Behavioral Therapy for Depression	437
Trends in US Emergency Department Visits for Mental Health, Overdose, and Violence Outcomes Before and During the COVID-19 Pandemic	399
Association Between Physical Activity and Risk of Depression	347
Addressing the COVID-19 Pandemic in Populations With Serious Mental Illness	346
Perturbations in Gut Microbiota Composition in Psychiatric Disorders	319
Prevention of Psychosis	297
How COVID-19 Affects the Brain	289
Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence	276
Association of Psychiatric Disorders With Mortality Among Patients With COVID-19	248
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder	240
Effectiveness, Core Elements, and Moderators of Response of Cognitive Remediation for Schizophrenia	231
From Basic Science to Clinical Application of Polygenic Risk Scores	202
Psychotherapy for Depression Across Different Age Groups: A Systematic Review and Meta-analysis	178
Associations of Depression, Anxiety, Worry, Perceived Stress, and Loneliness Prior to Infection With Risk of Post–COVID-19 Conditions	168
Could Polygenic Risk Scores Be Useful in Psychiatry?	167
Psychosocial Interventions and Immune System Function	165
Associations Between Prenatal Cannabis Exposure and Childhood Outcomes	163
Evaluation of Increases in Drug Overdose Mortality Rates in the US by Race and Ethnicity Before and During the COVID-19 Pandemic	163
Neurobiology, Clinical Presentation, and Treatment of Methamphetamine Use Disorder	162
Mental Health in the Coronavirus Disease 2019 Emergency—The Italian Response	161
Association Between Mood Disorders and Risk of COVID-19 Infection, Hospitalization, and Death	161
Probability of Transition to Psychosis in Individuals at Clinical High Risk	160
Dissecting the Association Between Inflammation, Metabolic Dysregulation, and Specific Depressive Symptoms	158

Association Between Mental Health Disorders and Mortality Among Patients With COVID-19 in 7 Countries	158
Methamphetamine Use, Methamphetamine Use Disorder, and Associated Overdose Deaths Among US Adults	152
Posttraumatic Stress Disorder in Patients After Severe COVID-19 Infection	149
Telepsychiatry and the Coronavirus Disease 2019 Pandemic—Current and Future Outcomes of the Rapid Virtualization of Psychiatric Care	148
Multimodal Machine Learning Workflows for Prediction of Psychosis in Patients With Clinical High-Risk Syndromes and Recent-Onset Depression	141
Functional Magnetic Resonance Imaging–Guided Personalization of Transcranial Magnetic Stimulation Treatment for Depression	139
Association of OPRM1 Functional Coding Variant With Opioid Use Disorder	137
Immediate and Longer-Term Changes in the Mental Health and Well-being of Older Adults in England During the COVID-19 Pandemic	134
Virtual Histology of Cortical Thickness and Shared Neurobiology in 6 Psychiatric Disorders	130
Dialectical Behavior Therapy for Posttraumatic Stress Disorder (DBT-PTSD) Compared With Cognitive Processing Therapy (CPT) in Complex Presentations of PTSD in Women Survivors of Childhood Abuse	129
Association of Symptoms of Depression With Cardiovascular Disease and Mortality in Low-, Middle-, and High-Income Countries	126
Adjunctive Psychotherapy for Bipolar Disorder	125
Association of Suicide Prevention Interventions With Subsequent Suicide Attempts, Linkage to Follow-up Care, and Depression Symptoms for Acute Care Settings	122
The Coronavirus Disease 2019 (COVID-19) Outbreak and Mental Health	120
Association of Outdoor Artificial Light at Night With Mental Disorders and Sleep Patterns Among US Adolescents	119
The Current Status of Psychedelics in Psychiatry	119
Inflammation and Brain Structure in Schizophrenia and Other Neuropsychiatric Disorders	115
Effect of Layperson-Delivered, Empathy-Focused Program of Telephone Calls on Loneliness, Depression, and Anxiety Among Adults During the COVID-19 Pandemic	114
Effect of Zuranolone vs Placebo in Postpartum Depression	113
Psychosocial Stressors at Work and the Risk of Sickness Absence Due to a Diagnosed Mental Disorder	112
Effect of Long-Acting Injectable Antipsychotics vs Usual Care on Time to First Hospitalization in Early-Phase Schizophrenia	112
Reward-Processing Behavior in Depressed Participants Relative to Healthy Volunteers	110
Association of High-Potency Cannabis Use With Mental Health and Substance Use in Adolescence	107
Effect of Pain Reprocessing Therapy vs Placebo and Usual Care for Patients With Chronic Back Pain	106
Neurocognitive Functioning in Individuals at Clinical High Risk for Psychosis	106
Association of CYP2C19 and CYP2D6 Poor and Intermediate Metabolizer Status With Antidepressant and Antipsychotic Exposure	103
Transcriptomic Landscape and Functional Characterization of Induced Pluripotent Stem Cell–Derived Cerebral Organoids in Schizophrenia	103
The Genetic Architecture of Depression in Individuals of East Asian Ancestry	102
Association of Drug Cues and Craving With Drug Use and Relapse	101
Coached Mobile App Platform for the Treatment of Depression and Anxiety Among Primary Care Patients	101
Prescription Opioid Use and Risk for Major Depressive Disorder and Anxiety and Stress-Related Disorders	100
Opportunities From the Coronavirus Disease 2019 Pandemic for Transforming Psychiatric Care With Telehealth	97
Racial Differences in Statewide Suicide Mortality Trends in Maryland During the Coronavirus Disease 2019 (COVID-19) Pandemic	97
National Trends in Mental Health Care for US Adolescents	96
Etiology of Autism Spectrum Disorders and Autistic Traits Over Time	95
Factors Associated With Real-Life Functioning in Persons With Schizophrenia in a 4-Year Follow-up Study of the Italian Network for Research on Psychoses	92
Joint International Collaboration to Combat Mental Health Challenges During the Coronavirus Disease 2019 Pandemic	89
Association of Cannabis Use During Adolescence With Neurodevelopment	89
Association of Preeclampsia in Term Births With Neurodevelopmental Disorders in Offspring	87
Sequential Combination of Pharmacotherapy and Psychotherapy in Major Depressive Disorder	85
Prevalence and Correlates of Suicide and Nonsuicidal Self-injury in Children	84
Prevention of Incident and Recurrent Major Depression in Older Adults With Insomnia	83
Association of Structural Magnetic Resonance Imaging Measures With Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis	82
Association Between Ambient Heat and Risk of Emergency Department Visits for Mental Health Among US Adults, 2010 to 2019	81
Methamphetamine Overdose Deaths in the US by Sex and Race and Ethnicity	81
Social Isolation and Loneliness in Older Adults—A Mental Health/Public Health Challenge	79
Effects of Antipsychotic Medication on Brain Structure in Patients With Major Depressive Disorder and Psychotic Features	78
Identification of Suicide Attempt Risk Factors in a National US Survey Using Machine Learning	78
Cortical Proteins Associated With Cognitive Resilience in Community-Dwelling Older Persons	78
Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level	77

Association of US Nurse and Physician Occupation With Risk of Suicide	75
Association Between Cardiovascular Risk Factors and Cognitive Impairment in People With Schizophrenia	74
Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic	74
Quantifying Deviations of Brain Structure and Function in Major Depressive Disorder Across Neuroimaging Modalities	74
Contingency Management for Patients Receiving Medication for Opioid Use Disorder	73
Emergency Department Encounters Among Youth With Suicidal Thoughts or Behaviors During the COVID-19 Pandemic	73
Prediction, Not Association, Paves the Road to Precision Medicine	73
Suicide Prevention in the COVID-19 Era	73
Association of Mental Disorder in Childhood and Adolescence With Subsequent Educational Achievement	72
Association of Screen Time With Internalizing and Externalizing Behavior Problems in Children 12 Years or Younger	72
Stratified Care vs Stepped Care for Depression	71
Association of Antihypertensive Drug Target Genes With Psychiatric Disorders	69
Overdose-Related Cardiac Arrests Observed by Emergency Medical Services During the US COVID-19 Epidemic	69
Telehealth for Substance-Using Populations in the Age of Coronavirus Disease 2019	68
Cortical Thickness Abnormalities at Different Stages of the Illness Course in Schizophrenia	67
Effect of Cognitive Bias Modification on Early Relapse Among Adults Undergoing Inpatient Alcohol Withdrawal Treatment	67
Effect of Internet vs Face-to-Face Cognitive Behavior Therapy for Health Anxiety	65
Maternal Use of Specific Antidepressant Medications During Early Pregnancy and the Risk of Selected Birth Defects	63
Association of Hypothyroidism and Clinical Depression	63
Association of Schizophrenia Spectrum Disorders and Violence Perpetration in Adults and Adolescents From 15 Countries	63
Findings From World Mental Health Surveys of the Perceived Helpfulness of Treatment for Patients With Major Depressive Disorder	60
Age-Specific Prevalence and Incidence of Dementia Diagnoses Among Older US Adults With Schizophrenia	60
Reinforcement Learning in Patients With Mood and Anxiety Disorders vs Control Individuals	60
Will Legalization and Commercialization of Cannabis Use Increase the Incidence and Prevalence of Psychosis?	59
Development of Proteomic Prediction Models for Transition to Psychotic Disorder in the Clinical High-Risk State and Psychotic Experiences in Adolescence	58
Characterizing Heterogeneity in Neuroimaging, Cognition, Clinical Symptoms, and Genetics Among Patients With Late-Life Depression	57
Genetic Associations Between Childhood Psychopathology and Adult Depression and Associated Traits in 42 998 Individuals	56
Representation and Outcomes of Individuals With Schizophrenia Seen in Everyday Practice Who Are Ineligible for Randomized Clinical Trials	56
Trends in Suicidality 1 Year Before and After Birth Among Commercially Insured Childbearing Individuals in the United States, 2006-2017	55
Longitudinal Associations of Mental Disorders With Dementia	55
Efficacy and Safety of Ketamine vs Electroconvulsive Therapy Among Patients With Major Depressive Episode	54
Preaddiction—A Missing Concept for Treating Substance Use Disorders	54
Cost-effectiveness of Treatments for Opioid Use Disorder	54
Effectiveness of Sequential Psychological and Medication Therapies for Insomnia Disorder	53
Social Cognitive Performance in Schizophrenia Spectrum Disorders Compared With Autism Spectrum Disorder	53
Association of Naturalistic Administration of Cannabis Flower and Concentrates With Intoxication and Impairment	53
Outcomes of Randomized Clinical Trials of Interventions to Enhance Social, Emotional, and Spiritual Components of Wisdom	53
Combining Antidepressants vs Antidepressant Monotherapy for Treatment of Patients With Acute Depression	52
Association of Racial Discrimination With Neural Response to Threat in Black Women in the US Exposed to Trauma	52
Effects of SlowMo, a Blended Digital Therapy Targeting Reasoning, on Paranoia Among People With Psychosis	52
Meeting Maternal Mental Health Needs During the COVID-19 Pandemic	52
A Development Pathway Towards Precision Mental Health Care	51
Reinforcement Learning Disruptions in Individuals With Depression and Sensitivity to Symptom Change Following Cognitive Behavioral Therapy	51
Racial/Ethnic Disparities in the Performance of Prediction Models for Death by Suicide After Mental Health Visits	51
Genetic Association Between Schizophrenia and Cortical Brain Surface Area and Thickness	50
Management of Patients With Severe Mental Illness During the Coronavirus Disease 2019 Pandemic	50
Psychedelics in Psychiatry—Keeping the Renaissance From Going Off the Rails	50
Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia	50
Efficacy of Yoga vs Cognitive Behavioral Therapy vs Stress Education for the Treatment of Generalized Anxiety Disorder	50
Maximizing the Uptake of a COVID-19 Vaccine in People With Severe Mental Illness	49
Effect of Aspirin vs Placebo on the Prevention of Depression in Older People	49
The Healthy Brain and Child Development Study—Shedding Light on Opioid Exposure, COVID-19, and Health Disparities	49
Association of Attention-Deficit/Hyperactivity Disorder in Childhood and Adolescence With the Risk of Subsequent Psychotic Disorder	49
Suicide Prevention Research Priorities in Health Care	49
Trends in the Incidence and Lethality of Suicidal Acts in the United States, 2006 to 2015	48
Can Sophisticated Study Designs With Regression Analyses of Observational Data Provide Causal Inferences?	48
Longitudinal Trends in Childhood Insulin Levels and Body Mass Index and Associations With Risks of Psychosis and Depression in Young Adults	48
Comparison of Driving Times to Opioid Treatment Programs and Pharmacies in the US	48
Use of Medications for Alcohol Use Disorder in the US	48
Racial/Ethnic, Social, and Geographic Trends in Overdose-Associated Cardiac Arrests Observed by US Emergency Medical Services During the COVID-19 Pandemic	48
Mortality Associated With Mental Disorders and Comorbid General Medical Conditions	47
Identification of Neuropsychiatric Copy Number Variants in a Health Care System Population	47
Effectiveness of Standard Sequential Bilateral Repetitive Transcranial Magnetic Stimulation vs Bilateral Theta Burst Stimulation in Older Adults With Depression	47
Effect of Culturally Tailored, Internet-Delivered Cognitive Behavioral Therapy for Insomnia in Black Women	47
Development Over Time of the Population-Attributable Risk Fraction for Cannabis Use Disorder in Schizophrenia in Denmark	46
Why Deaths of Despair Are Increasing in the US and Not Other Industrial Nations—Insights From Neuroscience and Anthropology	46
Methadone-Involved Overdose Deaths in the US Before and After Federal Policy Changes Expanding Take-Home Methadone Doses From Opioid Treatment Programs	46
Implementation and Effectiveness of Nonspecialist-Delivered Interventions for Perinatal Mental Health in High-Income Countries	46
Preparing for the Bursting of the Psychedelic Hype Bubble	46
Treatment of Patients With Anorexia Nervosa in the US—A Crisis in Care	45
Studying Harms Is Key to Improving Psychedelic-Assisted Therapy—Participants Call for Changes to Research Landscape	45
Examination of Dosing of Antipsychotic Drugs for Relapse Prevention in Patients With Stable Schizophrenia	45
Mindfulness-Based Stress Reduction vs Escitalopram for the Treatment of Adults With Anxiety Disorders	45
Functional Connectivity in Antipsychotic-Treated and Antipsychotic-Naive Patients With First-Episode Psychosis and Low Risk of Self-harm or Aggression	44
Neuropsychiatric and Cognitive Outcomes in Patients 6 Months After COVID-19 Requiring Hospitalization Compared With Matched Control Patients Hospitalized for Non–COVID-19 Illness	44
Religious Service Attendance and Deaths Related to Drugs, Alcohol, and Suicide Among US Health Care Professionals	44
Prevalence and Risk Factors Associated With Attention-Deficit/Hyperactivity Disorder Among US Black Individuals	44
Immediate and Sustained Outcomes and Moderators Associated With Metacognitive Training for Psychosis	44
Effectiveness of Predominantly Group Schema Therapy and Combined Individual and Group Schema Therapy for Borderline Personality Disorder	44
Risk of Suicide Attempt in Patients With Recent Diagnosis of Mild Cognitive Impairment or Dementia	44

Associations Between Schizophrenia Polygenic Liability, Symptom Dimensions, and Cognitive Ability in Schizophrenia	43
Assessment of Noninvasive Brain Stimulation Interventions for Negative Symptoms of Schizophrenia	42
Race as a Social Construct in Psychiatry Research and Practice	42
Assessment of Neurobiological Mechanisms of Cortical Thinning During Childhood and Adolescence and Their Implications for Psychiatric Disorders	42
Family Genetic Risk Scores and the Genetic Architecture of Major Affective and Psychotic Disorders in a Swedish National Sample	42
Prevalence and Trends in Suicidal Behavior Among US Military Veterans During the COVID-19 Pandemic	42
Methadone for Opioid Use Disorder—Decades of Effectiveness but Still Miles Away in the US	41
Driving Performance and Cannabis Users’ Perception of Safety	41
Long-term Exposure to Multiple Ambient Air Pollutants and Association With Incident Depression and Anxiety	41
Association of Brain Reward Response With Body Mass Index and Ventral Striatal-Hypothalamic Circuitry Among Young Women With Eating Disorders	41
Association of Recent Stressful Life Events With Mental and Physical Health in the Context of Genomic and Exposomic Liability for Schizophrenia	40
Going Upstream to Advance Psychosis Prevention and Improve Public Health	40
Role of the Gut-Brain Axis in the Shared Genetic Etiology Between Gastrointestinal Tract Diseases and Psychiatric Disorders	40
The Differential Outcomes of Coronavirus Disease 2019 in Low- and Middle-Income Countries vs High-Income Countries	40
Cerebrospinal Fluid Biomarkers in Patients With Unipolar Depression Compared With Healthy Control Individuals	40
Current Epidemiological Trends in Firearm Mortality in the United States	40
Prevalence of Perinatal Depression in Low- and Middle-Income Countries	40
Effect of Gonadotropin-Releasing Hormone Antagonist on Risk of Committing Child Sexual Abuse in Men With Pedophilic Disorder	40
Association of Nondiscrimination Policies With Mental Health Among Gender Minority Individuals	39
Association Between Race/Ethnicity and Disparities in Health Care Use Before First-Episode Psychosis Among Privately Insured Young Patients	39
Association of Social Determinants of Health and Vaccinations With Child Mental Health During the COVID-19 Pandemic in the US	39
Psychedelic Drug Legislative Reform and Legalization in the US	39
Novel Risk Loci Associated With Genetic Risk for Bipolar Disorder Among Han Chinese Individuals	39
Association of Multigenerational Family History of Depression With Lifetime Depressive and Other Psychiatric Disorders in Children	39
Lithium Treatment in the Prevention of Repeat Suicide-Related Outcomes in Veterans With Major Depression or Bipolar Disorder	39
Mood Homeostasis Before and During the Coronavirus Disease 2019 (COVID-19) Lockdown Among Students in the Netherlands	39
Suicide Risk in Medicare Patients With Schizophrenia Across the Life Span	38
Association of History of Psychopathology With Accelerated Aging at Midlife	38
Association of Youth Depression With Subsequent Somatic Diseases and Premature Death	38
Genetically Proxied Diurnal Preference, Sleep Timing, and Risk of Major Depressive Disorder	38
Removing the Reliability Bottleneck in Functional Magnetic Resonance Imaging Research to Achieve Clinical Utility	38
Socioeconomic Indicators of Treatment Prognosis for Adults With Depression	37
Accuracy Requirements for Cost-effective Suicide Risk Prediction Among Primary Care Patients in the US	37
Association of Treatment-Resistant Depression With Patient Outcomes and Health Care Resource Utilization in a Population-Wide Study	37
Associations Between Neuropsychiatric Symptoms and Neuropathological Diagnoses of Alzheimer Disease and Related Dementias	37
Discriminating Heterogeneous Trajectories of Resilience and Depression After Major Life Stressors Using Polygenic Scores	37
The Rapid Rise in Investment in Psychedelics—Cart Before the Horse	36
Changes and Inequities in Adult Mental Health–Related Emergency Department Visits During the COVID-19 Pandemic in the US	36
Bridging Knowledge Gaps in the Diagnosis and Management of Neuropsychiatric Sequelae of COVID-19	36
Psychotropic Medication Use and Psychiatric Disorders During the COVID-19 Pandemic Among Danish Children, Adolescents, and Young Adults	36
Neurodevelopmental Disorders Among Publicly or Privately Insured Children in the United States	35
Pragmatic Precision Psychiatry—A New Direction for Optimizing Treatment Selection	35
A Framework for Advancing Precision Medicine in Clinical Trials for Mental Disorders	35
National Trends of Mental Health Care Among US Adults Who Attempted Suicide in the Past 12 Months	35
Effectiveness of a Guided Web-Based Self-help Intervention to Prevent Depression in Patients With Persistent Back Pain	35
Prospective Development and Validation of the Computerized Adaptive Screen for Suicidal Youth	35
Effect of Shamiri Layperson-Provided Intervention vs Study Skills Control Intervention for Depression and Anxiety Symptoms in Adolescents in Kenya	35
Use of Genetically Informed Methods to Clarify the Nature of the Association Between Cannabis Use and Risk for Schizophrenia	35
Neuroinflammation After COVID-19 With Persistent Depressive and Cognitive Symptoms	34
Association of Borderline Personality Disorder Criteria With Suicide Attempts	34
Continuation of Antidepressants vs Sequential Psychological Interventions to Prevent Relapse in Depression	34
Clinical Genetic Testing in Autism Spectrum Disorder in a Large Community-Based Population Sample	34
Risk of Early-Onset Depression Associated With Polygenic Liability, Parental Psychiatric History, and Socioeconomic Status	33
Association of Generalized Anxiety Disorder With Autonomic Hypersensitivity and Blunted Ventromedial Prefrontal Cortex Activity During Peripheral Adrenergic Stimulation	33
Use of the PsycheMERGE Network to Investigate the Association Between Depression Polygenic Scores and White Blood Cell Count	33
Time to Support Extensive Implementation of Shared Decision Making in Psychiatry	33
Targetable Biological Mechanisms Implicated in Emergent Psychiatric Conditions Associated With SARS-CoV-2 Infection	32
Comparison of Teleintegrated Care and Telereferral Care for Treating Complex Psychiatric Disorders in Primary Care	32
Interplay of Metabolome and Gut Microbiome in Individuals With Major Depressive Disorder vs Control Individuals	32
Effect of Online 1-Day Cognitive Behavioral Therapy–Based Workshops Plus Usual Care vs Usual Care Alone for Postpartum Depression	32
Neuropsychiatric Ramifications of Severe COVID-19 and Other Severe Acute Respiratory Infections	32
Psychiatry in Times of the Coronavirus Disease 2019 (COVID-19) Pandemic	31
Structural Magnetic Resonance Imaging All Over Again	31
Effectiveness of Transdiagnostic Cognitive-Behavioral Psychotherapy Compared With Management as Usual for Youth With Common Mental Health Problems	31
Efficacy of Adjunctive D-Cycloserine to Intermittent Theta-Burst Stimulation for Major Depressive Disorder	31
Association of Magnetoencephalographically Measured High-Frequency Oscillations in Visual Cortex With Circuit Dysfunctions in Local and Large-scale Networks During Emerging Psychosis	30
Tapering Antipsychotic Treatment	30
Predictive Modeling of Opioid Overdose Using Linked Statewide Medical and Criminal Justice Data	30
Association of Early-Life Mental Health With Biomarkers in Midlife and Premature Mortality	30
Association of the Mediterranean Dietary Approaches to Stop Hypertension Intervention for Neurodegenerative Delay (MIND) Diet With the Risk of Dementia	30
The Course of General Cognitive Ability in Individuals With Psychotic Disorders	30
Association of 24-Hour Activity Pattern Phenotypes With Depression Symptoms and Cognitive Performance in Aging	30
Individual Differences in Response to Antidepressants	29
Social Determinants of Mental Health	29
Association of Heavy Drinking With Deviant Fiber Tract Development in Frontal Brain Systems in Adolescents	28
The Origin of Our Modern Concept of Depression—The History of Melancholia From 1780-1880	28
Association of Childhood Adversities With Suicide Ideation and Attempts in Puerto Rican Young Adults	28
Association of Everyday Discrimination With Depressive Symptoms and Suicidal Ideation During the COVID-19 Pandemic in the All of Us Research Program	27
Mismatch Negativity in Response to Auditory Deviance and Risk for Future Psychosis in Youth at Clinical High Risk for Psychosis	27
Effect of Matching Therapists to Patients vs Assignment as Usual on Adult Psychotherapy Outcomes	27
Association Between the Duration of Untreated Psychosis and Selective Cognitive Performance in Community-Dwelling Individuals With Chronic Untreated Schizophrenia in Rural China	27
Prevalence, Comorbidity, and Sociodemographic Correlates of Psychiatric Diagnoses Reported in the All of Us Research Program	27
Opportunities for Research on the Treatment of Substance Use Disorders in the Context of COVID-19	27
The Rise of Venture Capital Investing in Mental Health	27
An Atlas of Genetic Correlations and Genetically Informed Associations Linking Psychiatric and Immune-Related Phenotypes	26
Associations Between Objective and Subjective Experiences of Childhood Maltreatment and the Course of Emotional Disorders in Adulthood	26
Mood Homeostasis, Low Mood, and History of Depression in 2 Large Population Samples	26
Multivariate, Transgenerational Associations of the COVID-19 Pandemic Across Minoritized and Marginalized Communities	26
Association of Mitochondrial Biogenesis With Variable Penetrance of Schizophrenia	26
Association of Insulin Resistance With Depression Severity and Remission Status	26
Therapist-Guided Internet-Delivered Cognitive Behavioral Therapy vs Internet-Delivered Supportive Therapy for Children and Adolescents With Social Anxiety Disorder	25
Maternal Mental Health and Infant Development During the COVID-19 Pandemic	25
Effect of Exercise, Escitalopram, or Placebo on Anxiety in Patients With Coronary Heart Disease	25
Development and Validation of a Model to Predict Posttraumatic Stress Disorder and Major Depression After a Motor Vehicle Collision	25
Sex Differences in Mental Health Problems and Psychiatric Hospitalization in Autistic Young Adults	25